(WRB) W. R. Berkley - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0844231029

Stock:

Total Rating 53

Risk 81

Buy Signal 0.00

Insurance - Property & Casualty +20.3
Property & Casualty Insurance +16.2

Market Cap: 27,248m
Avg Trading Vol: 136M USD

ATR: 2.28%
Peers RS (IBD): 38.64

Risk 5d forecast
Volatility	22.3%
Relative Tail Risk	-3.80%

Reward TTM
Sharpe Ratio	0.68
Alpha	12.17

Character TTM
Beta	0.300
Beta Downside	0.722

Drawdowns 3y
Max DD	17.44%
CAGR/Max DD	1.14

EPS (Earnings per Share)

EPS CAGR: 0.72%
EPS Trend: -8.1%

Last SUE: -0.14
Qual. Beats: 0

Revenue

Rev. CAGR: 6.71%
Rev. Trend: 94.5%

Last SUE: 3.11
Qual. Beats: 1

Description: WRB W. R. Berkley

W. R. Berkley Corporation, an insurance holding company, operates as a commercial line writer worldwide. The company operates in two segments, Insurance, and Reinsurance & Monoline Excess. The Insurance segment underwrites commercial insurance business, including excess and surplus lines, admitted lines, and specialty personal lines. This segment also provides accident and health insurance and reinsurance products; insurance for commercial risks; casualty and specialty environmental products; insurance coverages for fine arts and jewelry exposures; excess liability and inland marine coverage for small to medium-sized insureds; and commercial general liability, umbrella, professional liability, directors and officers, commercial property, and surety products, as well as products for technology, and life sciences and travel industries. In addition, it offers cyber risk solutions; crime and fidelity insurance products; medical professional coverages; workers' compensation insurance products; management liability and general insurance products; personal lines insurance solutions, including home, condo/co-op, auto, fine arts and collectibles, liability, collector vehicle, and recreational marine; law enforcement, public officials and educator's legal, and employment practices liability, as well as incidental medical, property, and crime insurance products; at-risk and alternative risk insurance program management services; professional liability; energy and marine risks; and insurance products to the Lloyd's marketplace. The Reinsurance & Monoline Excess segment provides treaty and facultative reinsurance solutions; property and casualty reinsurance products; facultative reinsurance products include automatic, semi-automatic, and individual risk assumed reinsurance; and turnkey products, such as cyber, employment practices liability insurance, liquor liability insurance and violent events. The company was founded in 1967 and is headquartered in Greenwich, Connecticut.

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income: 1.78b TTM > 0 and > 6% of Revenue
FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.06 > 1.0
NWC/Revenue: 18.57% < 20% (prev 230.3%; Δ -211.7% < -1%)
CFO/TA 0.08 > 3% & CFO 3.58b > Net Income 1.78b
Net Debt (353.8m) to EBITDA (2.37b): 0.15 < 3
Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities)
Outstanding Shares: last quarter (399.1m) vs 12m ago -0.44% < -2%
Gross Margin: 19.81% > 18% (prev 0.23%; Δ 1958 % > 0.5%)
Asset Turnover: 34.75% > 50% (prev 33.62%; Δ 1.13% > 0%)
Interest Coverage Ratio: 14.22 > 6 (EBITDA TTM 2.37b / Interest Expense TTM 126.9m)

Altman Z'' 0.26

A: 0.06 (Total Current Assets 2.73b - Total Current Liabilities 0.0) / Total Assets 44.07b
B: 0.30 (Retained Earnings 13.34b / Total Assets 44.07b)
C: 0.04 (EBIT TTM 1.80b / Avg Total Assets 42.32b)
D: -1.35 (Book Value of Equity 13.27b / Total Liabilities -9.81b)
Altman-Z'' Score: 0.26 = B

Beneish M

DSRI: none (Receivables none/6.92b, Revenue 14.71b/13.64b)
GMI: 1.16 (GM 19.81% / 22.89%)
AQI: none (AQ_t none / AQ_t-1 none)
SGI: 1.08 (Revenue 14.71b / 13.64b)
TATA: -0.04 (NI 1.78b - CFO 3.58b) / TA 44.07b)
Beneish M-Score: cannot calculate (missing components)

What is the price of WRB shares?

As of February 28, 2026, the stock is trading at USD 71.70 with a total of 4,799,417 shares traded.
Over the past week, the price has changed by +1.00%, over one month by +6.78%, over three months by -6.12% and over the past year by +18.66%.

Is WRB a buy, sell or hold?

W. R. Berkley has received a consensus analysts rating of 3.56. Therefor, it is recommend to hold WRB.

StrongBuy: 5
Buy: 1
Hold: 8
Sell: 2
StrongSell: 0

What are the forecasts/targets for the WRB price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	68.3	-4.7%
Analysts Target Price	68.3	-4.7%

WRB Fundamental Data Overview February 28, 2026

P/E Trailing = 16.1124
P/E Forward = 15.1976
P/S = 1.8526
P/B = 2.7829
P/EG = 10.8611
Revenue TTM = 14.71b USD
EBIT TTM = 1.80b USD
EBITDA TTM = 2.37b USD
Long Term Debt = 2.84b USD (from longTermDebt, two quarters ago)
Short Term Debt = 12.5m USD (from shortTermDebt, two quarters ago)
Debt = 2.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 353.8m USD (from netDebt column, last quarter)
Enterprise Value = 27.60b USD (27.25b + Debt 2.84b - CCE 2.49b)
Interest Coverage Ratio = 14.22 (Ebit TTM 1.80b / Interest Expense TTM 126.9m)
EV/FCF = 8.09x (Enterprise Value 27.60b / FCF TTM 3.41b)
FCF Yield = 12.36% (FCF TTM 3.41b / Enterprise Value 27.60b)
FCF Margin = 23.21% (FCF TTM 3.41b / Revenue TTM 14.71b)
Net Margin = 12.10% (Net Income TTM 1.78b / Revenue TTM 14.71b)
Gross Margin = 19.81% ((Revenue TTM 14.71b - Cost of Revenue TTM 11.79b) / Revenue TTM)
Gross Margin QoQ = 20.58% (prev 18.23%)
Tobins Q-Ratio = 0.63 (Enterprise Value 27.60b / Total Assets 44.07b)
Interest Expense / Debt = 1.11% (Interest Expense 31.6m / Debt 2.84b)
Taxrate = 20.49% (117.2m / 572.0m)
NOPAT = 1.43b (EBIT 1.80b * (1 - 20.49%))
Current Ratio = unknown (Total Current Assets 2.73b / Total Current Liabilities 0.0)
Debt / Equity = 0.29 (Debt 2.84b / totalStockholderEquity, last quarter 9.81b)
Debt / EBITDA = 0.15 (Net Debt 353.8m / EBITDA 2.37b)
Debt / FCF = 0.10 (Net Debt 353.8m / FCF TTM 3.41b)
Total Stockholder Equity = 9.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.20% (Net Income 1.78b / Total Assets 44.07b)
RoE = 18.82% (Net Income TTM 1.78b / Total Stockholder Equity 9.45b)
RoCE = 14.67% (EBIT 1.80b / Capital Employed (Equity 9.45b + L.T.Debt 2.84b))
RoIC = 11.78% (NOPAT 1.43b / Invested Capital 12.18b)
WACC = 6.44% (E(27.25b)/V(30.09b) * Re(7.02%) + D(2.84b)/V(30.09b) * Rd(1.11%) * (1-Tc(0.20)))
Discount Rate = 7.02% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.91%
[DCF] Terminal Value 85.38% ; FCFF base≈3.48b ; Y1≈3.92b ; Y5≈5.26b
[DCF] Fair Price = 346.8 (EV 131.14b - Net Debt 353.8m = Equity 130.79b / Shares 377.2m; r=6.44% [WACC]; 5y FCF grow 14.72% → 2.90% )
EPS Correlation: -8.08 | EPS CAGR: 0.72% | SUE: -0.14 | # QB: 0
Revenue Correlation: 94.48 | Revenue CAGR: 6.71% | SUE: 3.11 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.16 | Chg7d=+0.001 | Chg30d=-0.004 | Revisions Net=-3 | Analysts=15
EPS current Year (2026-12-31): EPS=4.58 | Chg7d=-0.032 | Chg30d=-0.057 | Revisions Net=-11 | Growth EPS=+5.7% | Growth Revenue=+4.7%
EPS next Year (2027-12-31): EPS=4.84 | Chg7d=-0.014 | Chg30d=-0.124 | Revisions Net=-8 | Growth EPS=+5.8% | Growth Revenue=+4.7%
[Analyst] Revisions Ratio: -0.23 (5 Up / 8 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.7% (Discount Rate 7.9% - Earnings Yield 6.2%)
[Growth] Growth Spread = +3.8% (Analyst 5.6% - Implied 1.7%)

Additional Sources for WRB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle